Loading...
01/11 16:17
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance, strategic growth through AI and partnerships, and optimistic guidance. While there are concerns about unclear management responses on payment adoption and future investments, the overall sentiment remains positive due to expected revenue growth, profitability improvements, and strategic initiatives. The market strategy and shareholder return plan are well-received, with plans for increased leverage and focus on high-potential verticals. Despite some uncertainties, the positive outlook on growth and profitability, along with strategic developments, suggests a positive stock price movement.
Revenue $61.3 million, accelerating year-over-year growth rate to 17.1%. This marks the 15th consecutive quarter of exceeding the top end of revenue guidance.
Gross Margin Reached a record high of 73%, more than 15 percentage points higher than at IPO 4 years ago. Improvements were driven by leveraging cloud data center costs and hardware amortization.
Free Cash Flow $5 million, reflecting disciplined execution and the efficiency and scalability of the business.
Payments Revenue Grew at more than double the rate of total revenue, driven by the launch of surcharging and bulk collection features.
Gross Revenue Retention Held steady at 90% in Q3, indicating strong customer retention.
Net Revenue Retention 94%, with a decrease due to lapping the effects of a price increase in Q2 2024 and higher churn in new verticals like specialty medical.
Operating Income $1.7 million, an improvement of $300,000 compared to Q3 2024, representing an operating margin of 2.7%.
Cash and Short-term Investments $80.3 million, an increase of more than $2 million sequentially, reflecting strong liquidity.
AI receptionist: Expanded capabilities to handle incoming patient calls directly, intelligently route inquiries, and manage scheduling via voice or text. Strong interest from single-location customers and mid-market accounts.
Call intelligence: Analyzes call recordings to detect customer sentiment and identify patient needs and revenue opportunities. Expanded capabilities to unify human and AI-driven interactions.
Payments platform: Launched surcharging and bulk collection features to manage costs and save time for office staff.
Specialty medical vertical: Delivered record results with the highest number of medical location additions in company history. Represents a significant long-term opportunity as it is more than triple the size of dental, optometry, and veterinary combined.
Mid-market expansion: Signed a contract with a 600+ location specialty medical group, with potential to become one of the largest customers. Expanded traction across multiple healthcare segments.
Revenue growth: Generated $61.3 million in revenue, a 17.1% year-over-year growth rate. Achieved 15 consecutive quarters of exceeding revenue guidance.
Gross margin: Reached a record high of 73%, reflecting scalability and efficiency.
Free cash flow: Generated $5 million in free cash flow, demonstrating disciplined execution.
AI innovation: Focused on intelligent automation to transform patient communication and workflows. Expanded AI receptionist and call intelligence capabilities.
Integration partnerships: Launched multiple new integrations, doubling to quintupling sales of integrated solutions year-over-year.
Staffing shortages in SMB healthcare practices: More than 70% of SMB healthcare practices report difficulty in hiring and retaining front desk staff, which disrupts patient communication and daily operations. This remains the #1 operational challenge for these practices.
Regulatory compliance and security risks: Competitors may struggle to meet the high standards of security, regulatory compliance, and reliability required in healthcare, which are critical for maintaining customer trust and avoiding legal risks.
Churn in new verticals: Entering new verticals like specialty medical has led to higher churn and lower average sales prices initially, which could pressure overall retention metrics and financial performance.
Dependence on AI and automation: While AI and automation are central to Weave's strategy, over-reliance on these technologies could pose risks if they fail to meet customer expectations or if competitors develop superior solutions.
Economic uncertainties: Although not explicitly mentioned, economic uncertainties could impact customer acquisition and retention, especially in SMB markets that are sensitive to broader economic conditions.
Revenue Guidance: The company is raising the midpoint of its full-year revenue guidance to a range of $238 million to $239 million. For Q4 2025, total revenue is expected to be in the range of $62.4 million to $63.4 million.
Non-GAAP Operating Income Guidance: The company is raising its full-year non-GAAP operating income guidance to a range of $3.3 million to $4.3 million. For Q4 2025, non-GAAP operating income is expected to be in the range of $1.5 million to $2.5 million.
AI and Automation Expansion: The company plans to expand the capabilities of its AI receptionist, including introducing voice capabilities later this quarter to handle incoming patient calls and route inquiries intelligently. Sales efforts for the AI receptionist will extend to new single-location customers in November.
Specialty Medical Vertical Growth: Specialty medical is emerging as a key growth driver, delivering record results with the highest number of medical location additions in company history. This vertical represents a significant long-term opportunity as it is more than triple the size of dental, optometry, and veterinary combined.
Mid-Market Growth: The mid-market segment continues to grow, with expanding traction across multiple healthcare segments. A recent contract with a 600-plus location specialty medical group highlights this growth, with the initial phase including 50 locations already onboarding.
Payments Platform Growth: Payments revenue is growing at more than double the rate of total revenue. Recent launches include surcharging and bulk collection features, which are expected to strengthen the value proposition for multi-location and enterprise customers.
The selected topic was not discussed during the call.
The earnings call highlights strong financial performance, strategic growth through AI and partnerships, and optimistic guidance. While there are concerns about unclear management responses on payment adoption and future investments, the overall sentiment remains positive due to expected revenue growth, profitability improvements, and strategic initiatives. The market strategy and shareholder return plan are well-received, with plans for increased leverage and focus on high-potential verticals. Despite some uncertainties, the positive outlook on growth and profitability, along with strategic developments, suggests a positive stock price movement.
The earnings call highlights strong growth in specialty medical, successful integration of TrueLark, and positive customer feedback. The company's strategic investments in R&D and sales/marketing, along with raised revenue guidance, indicate a positive outlook. While there are some uncertainties regarding AI adoption and macroeconomic impacts, overall, the sentiment is positive due to strong demand, growth opportunities, and strategic plans. The Q&A section reinforces confidence in the company's direction, with analysts showing interest in growth strategies and integration progress.
The earnings call reveals strong financial performance with 18.3% revenue growth and improved gross margins. The acquisition of TrueLark is seen as a strategic complement, enhancing offerings and driving revenue. Despite increased expenses, operational efficiencies are evident with improved EBITDA. The Q&A section highlights resilience in market demand and competitive advantages. However, regulatory and operational risks are noted. Overall, the positive financial results, strategic acquisition, and market resilience suggest a positive stock price movement.
The earnings call presents a mixed sentiment. Financial performance shows strong revenue growth and margin improvement, but the anticipated operating loss and negative free cash flow raise concerns. The acquisition of TrueLark is positive, offering cross-sell opportunities and revenue growth potential. The Q&A reveals optimism about market resilience and product integration, but management's lack of clarity on payment solutions' growth potential adds uncertainty. Overall, the sentiment is balanced, leaning neutral due to financial strain and management's vague responses.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
